Literature DB >> 11460527

A database for human fibrinogen variants.

M Hanss1, F Biot.   

Abstract

Identifying and studying abnormal human fibrinogens is a source of much information, and helps in taking care of the affected patients. To permit exhaustive numbering and easy updates, an extensive register has been compiled and made available on the internet. Known molecular abnormalities are mentioned with the essential clinical features.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11460527     DOI： 10.1111/j.1749-6632.2001.tb03495.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  35 in total

1.  Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.

Authors:  Roman Kotlín; Zuzana Reicheltová; Jirí Suttnar; Peter Salaj; Ingrid Hrachovinová; Tomás Riedel; Martin Malý; Milan Oravec; Jan Kvasnicka; Jan Evangelista Dyr
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

2.  The assembly of nonadhesive fibrinogen matrices depends on the αC regions of the fibrinogen molecule.

Authors:  Ivan S Yermolenko; Oleg V Gorkun; Alexander Fuhrmann; Nataly P Podolnikova; Valeryi K Lishko; Stanislav P Oshkadyerov; Susan T Lord; Robert Ros; Tatiana P Ugarova
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

3.  Severe bleeding in a woman heterozygous for the fibrinogen gammaR275C mutation.

Authors:  Chantelle M Rein; Brian L Anderson; Morgan M Ballard; Christopher M Domes; Joshua M Johnston; Russell Jared Madsen; Kathryn K M Wolper; Andrew S Terker; John M Strother; Thomas G Deloughery; David H Farrell
Journal:  Blood Coagul Fibrinolysis       Date:  2010-07       Impact factor: 1.276

Review 4.  What Is the Biological and Clinical Relevance of Fibrin?

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

Review 5.  Inherited risk factors for venous thromboembolism.

Authors:  Ida Martinelli; Valerio De Stefano; Pier M Mannucci
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

6.  Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking.

Authors:  Weixun Wang
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

7.  Structural Basis of Interfacial Flexibility in Fibrin Oligomers.

Authors:  Artem Zhmurov; Anna D Protopopova; Rustem I Litvinov; Pavel Zhukov; Alexander R Mukhitov; John W Weisel; Valeri Barsegov
Journal:  Structure       Date:  2016-09-29       Impact factor: 5.006

8.  High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; Marisa M Magaña; Ni-Cheng Liang; Xavier Soler; Daniel J Desantis; Debby Ngo; Virgil L Woods
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

9.  Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site.

Authors:  Veronica H Flood; Hamid A Al-Mondhiry; Chantelle M Rein; Kristine S Alexander; Rehana S Lovely; Kelley M Shackleton; Larry L David; David H Farrell
Journal:  Thromb Haemost       Date:  2008-06       Impact factor: 5.249

10.  Fibrinogen Yecheon: congenital dysfibrinogenemia with gamma methionine-310 to threonine substitution.

Authors:  Eunkyung Park; Geumbore Park; Rojin Park; Hee-Jin Kim; Sang Jae Lee; Young Joo Cha
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.